










<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://52.214.119.220/wiki/skins/common/feed.css?97"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://52.214.119.220/wiki/index.php?action=history&amp;feed=atom&amp;title=Human_Keto_Acyl_Reductase</id>
		<title>Human Keto Acyl Reductase - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://52.214.119.220/wiki/index.php?action=history&amp;feed=atom&amp;title=Human_Keto_Acyl_Reductase"/>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;action=history"/>
		<updated>2026-04-15T20:53:36Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.11.2</generator>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142546&amp;oldid=prev</id>
		<title>Michal Harel at 10:19, 12 January 2020</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142546&amp;oldid=prev"/>
				<updated>2020-01-12T10:19:55Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 10:19, 12 January 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;__TOC__&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;__TOC__&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;degects &lt;/del&gt;and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;defects &lt;/ins&gt;and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;See also [[Hydroxysteroid dehydrogenase]].&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;See also [[Hydroxysteroid dehydrogenase]].&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 16:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 16:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Crystal structure of human mitochondrial heteroterameric KAR is solved at 2.34 Å. The co-factors NAD is selectively bound to the HSD17B8 subunits whereas NADP is bound to the CBR4 subunits. Both NAD and NADP are stabilized by several conserved hydrogen bonding interactions in their respective binding sites. The Asp42, Arg12 and Arg 34 are the crucial residues for co-factor recognition. Acetate ion is also bound near NAD, which identifies the fatty acyl chain binding pocket. Ser 135, Tyr148 and Lys152 in CBR4 subunit are the catalytic triad residues involved in the catalysis. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Crystal structure of human mitochondrial heteroterameric KAR is solved at 2.34 Å. The co-factors NAD is selectively bound to the HSD17B8 subunits whereas NADP is bound to the CBR4 subunits. Both NAD and NADP are stabilized by several conserved hydrogen bonding interactions in their respective binding sites. The Asp42, Arg12 and Arg 34 are the crucial residues for co-factor recognition. Acetate ion is also bound near NAD, which identifies the fatty acyl chain binding pocket. Ser 135, Tyr148 and Lys152 in CBR4 subunit are the catalytic triad residues involved in the catalysis. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;bindig &lt;/del&gt;site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;binding &lt;/ins&gt;site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Michal Harel</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142545&amp;oldid=prev</id>
		<title>Michal Harel at 10:18, 12 January 2020</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142545&amp;oldid=prev"/>
				<updated>2020-01-12T10:18:41Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 10:18, 12 January 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;See also [[Hydroxysteroid dehydrogenase]].&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Disease==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Disease==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Michal Harel</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142543&amp;oldid=prev</id>
		<title>Michal Harel at 10:13, 12 January 2020</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142543&amp;oldid=prev"/>
				<updated>2020-01-12T10:13:06Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 10:13, 12 January 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='4cqm' size='240' side='right' caption='Human ketoacyl reductase complex with NADP (PDB code [[4cqm]])' scene=''&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='4cqm' size='240' side='right' caption='Human ketoacyl reductase complex with NADP (PDB code [[4cqm]])' scene=''&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;__TOC__&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Disease&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;--&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Disease&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Michal Harel</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142542&amp;oldid=prev</id>
		<title>Michal Harel at 10:12, 12 January 2020</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3142542&amp;oldid=prev"/>
				<updated>2020-01-12T10:12:28Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 10:12, 12 January 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Your Heading Here (maybe something like 'Structure')==Crystal structure of heterotetrameric human ketoacyl reductase complexed with NAD and NADP&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='4cqm' size='240' side='right' caption='Caption for this structure' scene=''&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;This is a default text for your page '''Human Keto Acyl Reductase'''. Click above on '''edit this page''' to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Function&lt;/del&gt;''' &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;StructureSection load=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;4cqm&lt;/ins&gt;' &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;size=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;240&lt;/ins&gt;' &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;side=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;right&lt;/ins&gt;' &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;caption='Human ketoacyl reductase complex with NADP (PDB code [[4cqm]])' scene=''&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==Function==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Disease&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==&lt;/ins&gt;Disease&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;--&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Relevance&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==&lt;/ins&gt;Relevance&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;All other mtFAS enzymes identified so far are encoded by a single gene while KAR complex is encoded by two different genes HSD17B8 and CBR4.Both subunits complement each other to form a stable quaternary structure as seen in the crystal structure. Further, the functional studies suggest that CBR4 is the functional subunit of KAR. Whereas, HSD17B8 works as a scaffold protein to facilitate the function and stability of KAR. HSD17B8 may works as an auxiliary fatty acid beta oxidation enzymes for the oxidation of 3R-hydroxyacyl-CoA metabolites.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;All other mtFAS enzymes identified so far are encoded by a single gene while KAR complex is encoded by two different genes HSD17B8 and CBR4.Both subunits complement each other to form a stable quaternary structure as seen in the crystal structure. Further, the functional studies suggest that CBR4 is the functional subunit of KAR. Whereas, HSD17B8 works as a scaffold protein to facilitate the function and stability of KAR. HSD17B8 may works as an auxiliary fatty acid beta oxidation enzymes for the oxidation of 3R-hydroxyacyl-CoA metabolites.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Structural highlights&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==&lt;/ins&gt;Structural highlights&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Crystal structure of human mitochondrial heteroterameric KAR is solved at 2.34 Å. The co-factors NAD is selectively bound to the HSD17B8 subunits whereas NADP is bound to the CBR4 subunits. Both NAD and NADP are stabilized by several conserved hydrogen bonding interactions in their respective binding sites. The Asp42, Arg12 and Arg 34 are the crucial residues for co-factor recognition. Acetate ion is also bound near NAD, which identifies the fatty acyl chain binding pocket. Ser 135, Tyr148 and Lys152 in CBR4 subunit are the catalytic triad residues involved in the catalysis. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Crystal structure of human mitochondrial heteroterameric KAR is solved at 2.34 Å. The co-factors NAD is selectively bound to the HSD17B8 subunits whereas NADP is bound to the CBR4 subunits. Both NAD and NADP are stabilized by several conserved hydrogen bonding interactions in their respective binding sites. The Asp42, Arg12 and Arg 34 are the crucial residues for co-factor recognition. Acetate ion is also bound near NAD, which identifies the fatty acyl chain binding pocket. Ser 135, Tyr148 and Lys152 in CBR4 subunit are the catalytic triad residues involved in the catalysis. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Michal Harel</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3022637&amp;oldid=prev</id>
		<title>Shiv K. Sah-Teli at 08:04, 5 April 2019</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3022637&amp;oldid=prev"/>
				<updated>2019-04-05T08:04:16Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 08:04, 5 April 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD bindig site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD bindig site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;  ghghhhhhh&amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Shiv K. Sah-Teli</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3022636&amp;oldid=prev</id>
		<title>Shiv K. Sah-Teli at 08:03, 5 April 2019</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3022636&amp;oldid=prev"/>
				<updated>2019-04-05T08:03:42Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 08:03, 5 April 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD bindig site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD bindig site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;  &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;ghghhhhhh&amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Shiv K. Sah-Teli</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013051&amp;oldid=prev</id>
		<title>Rajaram Venkatesan at 15:44, 15 March 2019</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013051&amp;oldid=prev"/>
				<updated>2019-03-15T15:44:18Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 15:44, 15 March 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 7:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 7:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;Disease &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/ins&gt;Disease&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;Relevance &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;All other mtFAS enzymes identified so far are encoded by a single gene while KAR complex is encoded by two different genes HSD17B8 and CBR4.Both subunits complement each other to form a stable quaternary structure as seen in the crystal structure. Further, the functional studies suggest that CBR4 is the functional subunit of KAR. Whereas, HSD17B8 works as a scaffold protein to facilitate the function and stability of KAR. HSD17B8 may works as an auxiliary fatty acid beta oxidation enzymes for the oxidation of 3R-hydroxyacyl-CoA metabolites.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/ins&gt;Relevance&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;All other mtFAS enzymes identified so far are encoded by a single gene while KAR complex is encoded by two different genes HSD17B8 and CBR4.Both subunits complement each other to form a stable quaternary structure as seen in the crystal structure. Further, the functional studies suggest that CBR4 is the functional subunit of KAR. Whereas, HSD17B8 works as a scaffold protein to facilitate the function and stability of KAR. HSD17B8 may works as an auxiliary fatty acid beta oxidation enzymes for the oxidation of 3R-hydroxyacyl-CoA metabolites.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;Structural highlights &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;Crystal structure of human mitochondrial heteroterameric KAR is solved at 2.34 Å. The co-factors NAD is selectively bound to the HSD17B8 subunits whereas NADP is bound to the CBR4 subunits. Both NAD and NADP are stabilized by several conserved hydrogen bonding interactions in their respective binding sites. The Asp42, Arg12 and Arg 34 are the crucial residues for co-factor recognition. Acetate ion is also bound near NAD, which identifies the fatty acyl chain binding pocket. Ser 135, Tyr148 and Lys152 in CBR4 subunit are the catalytic triad residues involved in the catalysis. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/ins&gt;Structural highlights&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Crystal structure of human mitochondrial heteroterameric KAR is solved at 2.34 Å. The co-factors NAD is selectively bound to the HSD17B8 subunits whereas NADP is bound to the CBR4 subunits. Both NAD and NADP are stabilized by several conserved hydrogen bonding interactions in their respective binding sites. The Asp42, Arg12 and Arg 34 are the crucial residues for co-factor recognition. Acetate ion is also bound near NAD, which identifies the fatty acyl chain binding pocket. Ser 135, Tyr148 and Lys152 in CBR4 subunit are the catalytic triad residues involved in the catalysis. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD bindig site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='80/809823/Cofactors/1'&amp;gt;Cofactors&amp;lt;/scene&amp;gt; are bound to the each subunit. &amp;lt;scene name='80/809823/Nad-a/2'&amp;gt;NAD&amp;lt;/scene&amp;gt; is bound in HSD17B8 subunit. &amp;lt;scene name='80/809823/Nadp-c/1'&amp;gt;NADP&amp;lt;/scene&amp;gt; is bound to the CBR4 subunit. &amp;lt;scene name='80/809823/Ethanediol/2'&amp;gt;1,2-Ethanediol&amp;lt;/scene&amp;gt; is bound near the NAD bindig site. &amp;lt;scene name='80/809823/Glycerol/2'&amp;gt;Glycerol&amp;lt;/scene&amp;gt; is also bound in the structure.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Rajaram Venkatesan</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013050&amp;oldid=prev</id>
		<title>Rajaram Venkatesan at 15:15, 15 March 2019</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013050&amp;oldid=prev"/>
				<updated>2019-03-15T15:15:28Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 15:15, 15 March 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Function The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/ins&gt;Function&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease == Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease == Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Rajaram Venkatesan</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013049&amp;oldid=prev</id>
		<title>Rajaram Venkatesan at 15:15, 15 March 2019</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013049&amp;oldid=prev"/>
				<updated>2019-03-15T15:15:02Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 15:15, 15 March 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;Function &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;== &lt;/del&gt;The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Function The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. Ketoacyl acyl-carrier-protein (ACP) reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease == Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease == Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Rajaram Venkatesan</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013048&amp;oldid=prev</id>
		<title>Rajaram Venkatesan at 15:13, 15 March 2019</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Human_Keto_Acyl_Reductase&amp;diff=3013048&amp;oldid=prev"/>
				<updated>2019-03-15T15:13:42Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 15:13, 15 March 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function == The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Keto &lt;/del&gt;acyl carrier protein reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function == The mitochondrial fatty acid synthesis (mtFAS) pathway generates precursors for mitochondrally generated alpha-lipoic acids. Defeciency of mtFAS leads to respiratory chain degects and mitochondrial dysfunction. The mtFAS has four enzymatic steps, catalyzed by four different enzymes. &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Ketoacyl &lt;/ins&gt;acyl&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;-&lt;/ins&gt;carrier&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;-&lt;/ins&gt;protein &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(ACP) &lt;/ins&gt;reductase (KAR) catalyzes the second step of mtFAS pathway, where 3-ketoacyl-ACP is reduced to 3R-hydroxyacyl-ACP utilizing NADPH as cofactor. KAR is a heterotetrameric complex made from two different polypeptides: 17β-hydroxysteroid dehydrogenase type 8 (HSD17B8 or KE6, α-subunit) and carbonyl reductase type 4 (CBR4 or SDR45C1, β-subunit)9. &amp;lt;ref&amp;gt;PMID:25203508&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease == Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease == Deficiency of the KAR or mtFAS pathway leads to respiratory chain defects and mitochondrial dysfunction in eukaryotes. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Rajaram Venkatesan</name></author>	</entry>

	</feed>